FibroBiologics, Inc. (FBLG)

NASDAQ: FBLG · Real-Time Price · USD

0.5056

+0.0152 (3.10%)

At close: Oct 8, 2025, 4:00 PM EDT

0.5049

-0.0007 (-0.14%)

Pre-market: Oct 9, 2025, 5:14 AM EDT

FibroBiologics Employees

FibroBiologics had 13 employees as of December 31, 2024. The number of employees increased by 3 or 30.00% compared to the previous year.

Employees

13

Change (1Y)

3

Growth (1Y)

30.00%

Revenue / Employee

n/a

Profits / Employee

-$1,017,154

Market Cap

21.18M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	13	3	30.00%
Dec 31, 2023	10	3	42.86%
Dec 31, 2022	7	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

FBLG News

15 days ago - FibroBiologics to Present at 2025 Cell & Gene Meeting on the Mesa - GlobeNewsWire
26 days ago - FibroBiologics Leadership Authors Opinion Editorial Highlighting Fibroblast Cells' Therapeutic Advantages Over Traditional Stem Cell Therapies - GlobeNewsWire
27 days ago - FibroBiologics Announces Positive IND-Enabling Updates Demonstrating Potential of Fibroblast Spheroids in Chronic-Relapse Psoriasis Treatment - GlobeNewsWire
4 weeks ago - FibroBiologics Announces Significant Advancements in Bone Marrow Organoid Platform Enabling Development for Cancer and Immune-Related Therapies - GlobeNewsWire
6 weeks ago - FibroBiologics to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
2 months ago - FibroBiologics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
2 months ago - FibroBiologics Files Patent for Methods of Generating Multipotent Cells from Donor Tissue for Clinical Applications - GlobeNewsWire
3 months ago - FibroBiologics to Present at the Advanced Wound Care Summit USA - GlobeNewsWire